Notícias

At the early stage of the pandemic, severe COVID-19 was thought to be rare among pregnant women. However, cumulating data...

Yupingfeng Powder (YPF), a kind of preventative patent medicine, is chosen for treatment of coronavirus disease 2019 (COVID-19) due to...

COVID-19 convalescent plasma (CCP), from donors recovered from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, is one of the limited...

Vaccine effectiveness against COVID-19 beyond 6 months remains incompletely understood. We aimed to investigate the effectiveness of COVID-19 vaccination against...

The global expansion of COVID-19 and the mutations of severe acute respiratory syndrome coronavirus necessitate quick development of treatment and...

In December 2019, a novel coronavirus disease (COVID-19) appeared in Wuhan, China. After that, it spread rapidly all over the...

A ABIFINA faz parte do Grupo de Trabalho Insumos, coordenado pela Câmara Temática de Insumos Agropecuários do Ministério da Agricultura,...

The recent outbreak of coronavirus disease 2019 (COVID-19) is a respiratory infection and it can spread from animal to person,...

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes severe viral pneumonia and is associated with a high fatality rate. A substantial...

SARS-CoV-2 infection is benign in most individuals but, in around 10% of cases, it triggers hypoxaemic COVID-19 pneumonia, which leads...

Although the three vaccines against coronavirus disease 2019 (Covid-19) that have received emergency use authorization in the United States are...

TMPRSS2 is a type II transmembrane protease with broad expression in epithelial cells of the respiratory and gastrointestinal tract, the...